Please login to the form below

Not currently logged in
Email:
Password:

New accounts: January

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive.

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry please email nhobson@pmlive.com

Client

Product

Therapeutic area

Winning agency

Alliance Pharmaceuticals

Alphaderm

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Aquadrate

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Acnisal

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Occlusal

Dermatology

RFA Advertising

AstraZeneca

Arimidex

Oncology

Brader Perryman

Amgen (Europe)

Aranesp

Anaemia

central branding

AstraZeneca

Nexium

Gastroenterology

RFA Advertising

Biogen

Avonex

Multiple sclerosis

Brader Perryman

Cambridge Laboratories

Gelclair

Oncology/ENT

RFA Advertising

Cambridge Laboratories

ImmuCyst

Oncology

RFA Advertising

Eden Biodesign

N/A

Corporate

Affiniti (UK)

Eli Lilly

Gemzar

Oncology

GSW-W

Novartis

Prexige

Osteoarthritis

Brader Perryman

Novartis

Exelon

Alzheimer's disease

Brader Perryman

Takeda

N/A

Corporate

Brader Perryman

Takeda

Actos

Diabetes

Brader Perryman

Takeda

Amias

Hypertension

Brader Perryman

Wyeth

Prostap

Gynaecology

Woolley Pau



2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics